Citigroup’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.08M | Sell |
14,400
-3,500
| -20% | -$1.9M | ﹤0.01% | 1703 |
|
|
2025
Q4 | $10.4M | Buy |
17,900
+5,300
| +42% | +$3M | ﹤0.01% | 1498 |
|
|
2025
Q3 | $6.11M | Sell |
12,600
-25,100
| -67% | -$11.7M | ﹤0.01% | 1837 |
|
|
2025
Q2 | $15.3M | Buy |
37,700
+29,600
| +365% | +$12.4M | 0.01% | 1121 |
|
|
2025
Q1 | $4.03M | Sell |
8,100
-7,200
| -47% | -$3.9M | ﹤0.01% | 2103 |
|
|
2024
Q4 | $7.96M | Buy |
15,300
+800
| +6% | +$440K | ﹤0.01% | 1549 |
|
|
2024
Q3 | $8.97M | Sell |
14,500
-6,500
| -31% | -$3.85M | 0.01% | 1397 |
|
|
2024
Q2 | $11.6M | Sell |
21,000
-4,100
| -16% | -$2.35M | 0.01% | 1173 |
|
|
2024
Q1 | $14.6M | Sell |
25,100
-65,200
| -72% | -$36.6M | 0.01% | 1043 |
|
|
2023
Q4 | $47.9M | Buy |
90,300
+67,200
| +291% | +$32.5M | 0.03% | 474 |
|
|
2023
Q3 | $11.7M | Sell |
23,100
-33,700
| -59% | -$18M | 0.01% | 1030 |
|
|
2023
Q2 | $29.6M | Sell |
56,800
-42,900
| -43% | -$23.2M | 0.02% | 651 |
|
|
2023
Q1 | $57.5M | Buy |
99,700
+36,900
| +59% | +$20.8M | 0.04% | 359 |
|
|
2022
Q4 | $34.6M | Buy |
62,800
+44,000
| +234% | +$23.3M | 0.03% | 536 |
|
|
2022
Q3 | $9.54M | Sell |
18,800
-35,000
| -65% | -$19.6M | 0.01% | 1167 |
|
|
2022
Q2 | $29.2M | Buy |
53,800
+19,600
| +57% | +$10.8M | 0.02% | 623 |
|
|
2022
Q1 | $20.2M | Sell |
34,200
-55,000
| -62% | -$31.6M | 0.01% | 943 |
|
|
2021
Q4 | $59.5M | Sell |
89,200
-92,200
| -51% | -$57.6M | 0.03% | 502 |
|
|
2021
Q3 | $104M | Buy |
181,400
+30,400
| +20% | +$16.7M | 0.06% | 285 |
|
|
2021
Q2 | $76.2M | Buy |
151,000
+37,900
| +34% | +$17.9M | 0.05% | 381 |
|
|
2021
Q1 | $51.6M | Sell |
113,100
-49,500
| -30% | -$23.6M | 0.03% | 483 |
|
|
2020
Q4 | $75.7M | Buy |
162,600
+114,900
| +241% | +$53.9M | 0.04% | 366 |
|
|
2020
Q3 | $21.1M | Sell |
47,700
-64,900
| -58% | -$26.8M | 0.01% | 878 |
|
|
2020
Q2 | $40.8M | Buy |
112,600
+44,000
| +64% | +$14.7M | 0.03% | 467 |
|
|
2020
Q1 | $19.5M | Buy |
68,600
+29,100
| +74% | +$9.18M | 0.02% | 752 |
|
|
2019
Q4 | $12.8M | Buy |
39,500
+1,500
| +4% | +$455K | 0.01% | 1274 |
|
|
2019
Q3 | $11.1M | Buy |
38,000
+15,600
| +70% | +$4.47M | 0.01% | 1318 |
|
|
2019
Q2 | $6.58M | Sell |
22,400
-4,500
| -17% | -$1.24M | 0.01% | 1745 |
|
|
2019
Q1 | $7.36M | Sell |
26,900
-11,700
| -30% | -$2.91M | 0.01% | 1482 |
|
|
2018
Q4 | $8.64M | Sell |
38,600
-8,100
| -17% | -$1.9M | 0.01% | 1367 |
|
|
2018
Q3 | $11.4M | Buy |
46,700
+23,500
| +101% | +$5.41M | 0.01% | 1195 |
|
|
2018
Q2 | $4.81M | Buy |
23,200
+500
| +2% | +$106K | ﹤0.01% | 1866 |
|
|
2018
Q1 | $4.69M | Sell |
22,700
-46,900
| -67% | -$9.84M | ﹤0.01% | 1832 |
|
|
2017
Q4 | $13.2M | Buy |
69,600
+48,000
| +222% | +$9.2M | 0.01% | 1090 |
|
|
2017
Q3 | $4.09M | Sell |
21,600
-5,300
| -20% | -$960K | ﹤0.01% | 1948 |
|
|
2017
Q2 | $4.69M | Sell |
26,900
-3,100
| -10% | -$521K | ﹤0.01% | 1744 |
|
|
2017
Q1 | $4.61M | Sell |
30,000
-4,500
| -13% | -$688K | ﹤0.01% | 1733 |
|
|
2016
Q4 | $4.87M | Sell |
34,500
-15,200
| -31% | -$2.24M | ﹤0.01% | 1870 |
|
|
2016
Q3 | $7.91M | Sell |
49,700
-19,300
| -28% | -$2.97M | 0.01% | 1259 |
|
|
2016
Q2 | $10.2M | Buy |
69,000
+39,400
| +133% | +$5.82M | 0.01% | 1024 |
|
|
2016
Q1 | $4.19M | Sell |
29,600
-102,500
| -78% | -$13.7M | ﹤0.01% | 1705 |
|
|
2015
Q4 | $18.7M | Sell |
132,100
-9,200
| -7% | -$1.23M | 0.02% | 754 |
|
|
2015
Q3 | $17.3M | Buy |
141,300
+5,700
| +4% | +$743K | 0.02% | 792 |
|
|
2015
Q2 | $17.6M | Buy |
135,600
+16,800
| +14% | +$2.19M | 0.02% | 853 |
|
|
2015
Q1 | $16M | Sell |
118,800
-4,900
| -4% | -$632K | 0.02% | 903 |
|
|
2014
Q4 | $15.5M | Sell |
123,700
-300
| -0.2% | -$36.5K | 0.01% | 951 |
|
|
2014
Q3 | $15.1M | Buy |
124,000
+95,500
| +335% | +$11.6M | 0.01% | 985 |
|
|
2014
Q2 | $3.36M | Buy |
+28,500
| New | +$3.35M | ﹤0.01% | 2116 |
|
Other funds holding TMO
VCM
Citigroup's TMO Position: Q1 2026 in Review
Citigroup increased its Thermo Fisher Scientific (TMO) stake by 6.6% in Q1 2026, buying an estimated $19.2M and bringing the position to 572,177 shares worth $281M. The position accounts for 0.12% of the portfolio, ranked #162.
Citigroup first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $620M in Q2 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Citigroup held 572,177 shares of Thermo Fisher Scientific worth $281M as of Q1 2026.
- Citigroup bought 35,391 Thermo Fisher Scientific shares in Q1 2026, an estimated $19.2M.
- Thermo Fisher Scientific made up 0.12% of Citigroup's portfolio in Q1 2026, its #162 holding.
- Citigroup first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Thermo Fisher Scientific position peaked at $620M in Q2 2024.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.